244 related articles for article (PubMed ID: 29636994)
1. Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.
Sheng J; Qin H; Zhang K; Li B; Zhang X
Am J Cancer Res; 2018; 8(3):354-365. PubMed ID: 29636994
[TBL] [Abstract][Full Text] [Related]
2. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
[TBL] [Abstract][Full Text] [Related]
3. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
[TBL] [Abstract][Full Text] [Related]
4. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.
Luo T; Fu J; Xu A; Su B; Ren Y; Li N; Zhu J; Zhao X; Dai R; Cao J; Wang B; Qin W; Jiang J; Li J; Wu M; Feng G; Chen Y; Wang H
Autophagy; 2016 Aug; 12(8):1355-71. PubMed ID: 25905985
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma.
Espelt MV; Bacigalupo ML; Carabias P; Troncoso MF
World J Hepatol; 2019 Apr; 11(4):344-358. PubMed ID: 31114639
[TBL] [Abstract][Full Text] [Related]
6. Activated hepatic stellate cells promote progression of post-heat residual hepatocellular carcinoma from autophagic survival to proliferation.
Zhang R; Lin XH; Liu HH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
Int J Hyperthermia; 2019; 36(1):253-263. PubMed ID: 30701994
[TBL] [Abstract][Full Text] [Related]
7. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Qiu SJ; Xu Y; Dai Z; Shi GM; Wang XY; Ke AW; Wu B; Fan J
Cancer Res; 2008 Nov; 68(22):9167-75. PubMed ID: 19010888
[TBL] [Abstract][Full Text] [Related]
8. Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma.
Chen R; Cheng Q; Owusu-Ansah KG; Chen J; Song G; Xie H; Zhou L; Xu X; Jiang D; Zheng S
Am J Cancer Res; 2018; 8(7):1297-1306. PubMed ID: 30094102
[TBL] [Abstract][Full Text] [Related]
9. Peptidylarginine deiminase IV promotes the development of chemoresistance through inducing autophagy in hepatocellular carcinoma.
Fan T; Zhang C; Zong M; Zhao Q; Yang X; Hao C; Zhang H; Yu S; Guo J; Gong R; Fan S; Wei L; Fan L
Cell Biosci; 2014; 4():49. PubMed ID: 25922661
[TBL] [Abstract][Full Text] [Related]
10. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.
Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC
Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866
[TBL] [Abstract][Full Text] [Related]
11. High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement.
Xie B; He X; Guo G; Zhang X; Li J; Liu J; Lin Y
Biochem Biophys Res Commun; 2020 Jan; 521(1):232-237. PubMed ID: 31653348
[TBL] [Abstract][Full Text] [Related]
12. Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma.
Kiruthiga C; Devi KP; Nabavi SM; Bishayee A
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32121322
[TBL] [Abstract][Full Text] [Related]
13. The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells.
Wang J; Wei H; Huang Y; Chen D; Zeng G; Lian Y; Huang Y
Aging (Albany NY); 2019 Aug; 11(15):5769-5785. PubMed ID: 31409760
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib.
Tong M; Che N; Zhou L; Luk ST; Kau PW; Chai S; Ngan ES; Lo CM; Man K; Ding J; Lee TK; Ma S
J Hepatol; 2018 Oct; 69(4):826-839. PubMed ID: 29885413
[TBL] [Abstract][Full Text] [Related]
15. Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma.
Torimura T; Iwamoto H; Nakamura T; Koga H; Ueno T; Kerbel RS; Sata M
Transl Oncol; 2013; 6(5):511-9. PubMed ID: 24151531
[TBL] [Abstract][Full Text] [Related]
16. Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells.
Peng WX; Xiong EM; Ge L; Wan YY; Zhang CL; Du FY; Xu M; Bhat RA; Jin J; Gong AH
Exp Cell Res; 2016 Jan; 340(1):62-70. PubMed ID: 26708617
[TBL] [Abstract][Full Text] [Related]
17. Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma.
Sun T; Liu H; Ming L
Cell Physiol Biochem; 2017; 44(2):716-727. PubMed ID: 29169150
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma.
Zhou Y; Wu PW; Yuan XW; Li J; Shi XL
Eur Rev Med Pharmacol Sci; 2016; 20(2):250-63. PubMed ID: 26875893
[TBL] [Abstract][Full Text] [Related]
19. Enhanced autophagic activity of artocarpin in human hepatocellular carcinoma cells through improving its solubility by a nanoparticle system.
Tzeng CW; Tzeng WS; Lin LT; Lee CW; Yen FL; Lin CC
Phytomedicine; 2016 May; 23(5):528-40. PubMed ID: 27064012
[TBL] [Abstract][Full Text] [Related]
20. ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.
Wu FQ; Fang T; Yu LX; Lv GS; Lv HW; Liang D; Li T; Wang CZ; Tan YX; Ding J; Chen Y; Tang L; Guo LN; Tang SH; Yang W; Wang HY
J Hepatol; 2016 Aug; 65(2):314-24. PubMed ID: 27154061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
